rhAPCRecombinant Human Activated Protein C
rhAPCRental Housing Association of Pierce County (Lakewood, WA)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Following preclinical investigations of septic shock showing that the administration of APC improved survival [226], the first reports describing the impact of rhAPC administration in humans with severe sepsis were published in 2001.
In the presence of severe circulatory failure along with progressive organ dysfunction unresponsiveness to standard therapy, it was decided to administer rhAPC. The patient's family was informed of the major risk of serious bleeding and consent was obtained.
At the initiation of the rhAPC infusion at 22 hours post-LT, the patient's coagulation profile was slightly abnormal (platelet count 57000 /[mciro]l, international normalised ratio 2.4, prothrombin time 28 seconds and activated prothrombin time 97 seconds).
PostLT patients with severe sepsis and multiorgan failure may benefit from the use of rhAPC, as it has the overall potential to markedly reduce the generalised inflammatory response.
There are, however, few published reports on the use of rhAPC in this group of patients.
A few reports in the literature discuss the use of rhAPC in the treatment of late onset sepsis in LT patients (6).
Approximately 750,000 patients per year are treated for sepsis, but rhAPC is intended for those who are treated in intensive care units for life-threatening sepsis, a group numbering about 325,000 per year.
Because rhAPC is an anticoagulant, no patients were enrolled if they were at high risk for bleeding.
He said he would consider using rhAPC in patients with recent gastrointestinal bleeding or bleeding into a wound, for example.
On the other hand, some patients "who looked like they were going to die" were ready to sit up and eat breakfast 24 hours after initiation of rhAPC therapy.
A "spectacular" response in baboons with disseminated intravascular coagulation led to the consideration of rhAPC in life-threatening sepsis in humans.
Therapies PBMC s from rhesus macaques [32] Anti-coagulant infected with ZEBOV and treated treatments for shortly after exposure with rNAPc2 Ebola virus or rhAPC. infection Omission from this table does not constitute absence of data.